Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies
Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies. What, why, how, etc., and cancer? I am open to the idea of repurposed drugs to fight cancer but my experience has taught me to be extremely careful.
Mebendazole is an antiparasitic drug that has been used safely for decades to treat intestinal worm infections. Recently, researchers have begun studying whether this inexpensive medication might also have anti-cancer effects.
Preclinical research suggests that mebendazole may interfere with cancer cell growth through several mechanisms including microtubule disruption, inhibition of tumor blood vessels, and induction of cancer cell death.
While research is still developing, studies have investigated mebendazole’s effects in a range of cancers including glioblastoma, melanoma, colon cancer, lung cancer, and breast cancer.
This article reviews the anti-tumor mechanisms of mebendazole and the current state of research.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. I have gone to great lengths and taken great risks in an effort to manage my blood cancer. I can understand why cancer patients hear about non-conventional therapies and want to understand more about them as possible therapies.
The post below is PeopleBeatingCancer.org’s effort to weigh in on the repurposed drugs and cancer debate. Please scroll down the page, post a question or a comment if you have any questions.
If you’d like to learn more about repurposed drugs and cancer treatment, click now.
Thank you,
David Emerson
Fenbendazole vs. Mebendazole: What’s the Difference?
What Is Mebendazole?
Mebendazole is a benzimidazole drug originally developed to treat parasitic infections such as:
- Pinworm
- Roundworm
- Whipworm
- Hookworm
It has been used worldwide since the 1970s and is considered a well-tolerated medication.
Because its mechanism of action disrupts microtubules, scientists realized that it may affect cancer cells in a way similar to some chemotherapy drugs.
Why Researchers Are Studying Mebendazole for Cancer
Drug repurposing is an area of increasing interest in oncology. Repurposed drugs already have:
- Known safety profiles
- Low cost
- Established manufacturing
Mebendazole has attracted attention because laboratory studies show it may affect several hallmarks of cancer simultaneously.
These potential actions include:
- Inhibiting tumor cell division
- Blocking tumor blood supply
- Triggering apoptosis (programmed cancer cell death)
- Affecting cancer stem cells
Anti-Tumor Mechanisms of Mebendazole
1. Microtubule Disruption
Mebendazole binds to β-tubulin, disrupting the microtubule structure that cells use for division.
Because rapidly dividing cancer cells rely heavily on microtubules, this disruption can lead to:
- Mitotic arrest
- Cell cycle arrest
- Tumor cell death
This mechanism is similar to chemotherapy drugs such as vincristine and paclitaxel.
Research example:
Nygren et al. demonstrated that mebendazole inhibited cancer cell growth through tubulin disruption.
https://pubmed.ncbi.nlm.nih.gov/20442352/
2. Anti-Angiogenesis (Blocking Tumor Blood Supply)
Tumors need to form new blood vessels in order to grow.
Mebendazole has been shown to inhibit VEGF signaling, which tumors use to stimulate blood vessel growth.
Inhibiting angiogenesis may:
- Starve tumors of oxygen
- Slow tumor growth
- Reduce metastasis potential
Study:
Dobrosotskaya et al. found that mebendazole inhibited tumor angiogenesis in experimental models.
https://pubmed.ncbi.nlm.nih.gov/24370321/
3. Inducing Apoptosis in Cancer Cells
Apoptosis is a natural process that eliminates damaged cells.
Cancer cells often develop ways to avoid apoptosis.
Research suggests that mebendazole may reactivate this process by:
- Increasing pro-apoptotic proteins
- Disrupting mitochondrial function
- Activating caspase pathways
Study:
Mukhopadhyay et al. reported apoptosis induction in lung cancer models.
https://pubmed.ncbi.nlm.nih.gov/25011444/
4. Inhibiting Cancer Cell Signaling Pathways
Mebendazole may interfere with important signaling pathways involved in tumor growth.
These include:
- Hedgehog signaling
- MAPK pathways
- VEGF pathways
Disruption of these pathways may reduce tumor proliferation and survival.
Study:
Larsen et al. reported inhibition of Hedgehog signaling in cancer models.
https://pubmed.ncbi.nlm.nih.gov/23748255/
5. Potential Effects on Cancer Stem Cells
Cancer stem cells are believed to contribute to:
- Tumor recurrence
- Treatment resistance
- Metastasis
Some research suggests mebendazole may affect these cells by interfering with microtubule function and cellular signaling.
This is an area of ongoing research.
Cancer Types Studied with Mebendazole
Although research is still early, mebendazole has been investigated in several cancer types.
Brain Cancer (Glioblastoma)
One of the most promising areas of research is glioblastoma.
A study from Johns Hopkins researchers found that mebendazole prolonged survival in mouse models of glioblastoma.
https://pubmed.ncbi.nlm.nih.gov/23393386/
Melanoma
Preclinical studies have shown that mebendazole may inhibit melanoma growth through microtubule disruption and apoptosis.
https://pubmed.ncbi.nlm.nih.gov/20442352/
Lung Cancer
Laboratory research suggests mebendazole may suppress lung cancer cell proliferation and induce apoptosis.
https://pubmed.ncbi.nlm.nih.gov/25011444/
Colorectal Cancer
Researchers have also investigated mebendazole’s effect on colon cancer cell lines, showing anti-proliferative effects.
https://pubmed.ncbi.nlm.nih.gov/24370321/
Clinical Evidence
While laboratory and animal studies are encouraging, human clinical trials remain limited.
Several early-stage clinical studies have been conducted or proposed to investigate mebendazole in cancers such as:
- Glioblastoma
- Adrenocortical cancer
- Colon cancer
Example clinical trial:
https://clinicaltrials.gov/ct2/show/NCT01729260
More clinical evidence is needed to determine:
- Optimal dosing
- Safety in oncology settings
- Effectiveness compared with standard treatments
Safety and Side Effects
Mebendazole has a long safety record as an antiparasitic medication.
Common side effects may include:
- Mild gastrointestinal discomfort
- Abdominal pain
- Diarrhea
Rare side effects include:
- Elevated liver enzymes
- Allergic reactions
However, doses used in cancer research may differ from traditional antiparasitic dosing, so medical supervision is important.
Integrative Oncology Perspective
Researchers studying drug repurposing often examine mebendazole as part of a multi-target strategy against cancer.
Integrative oncology approaches may combine:
- Conventional cancer therapies
- Repurposed medications
- Evidence-based lifestyle therapies
Lifestyle approaches shown to support cancer outcomes include:
- Anti-inflammatory diet
- Regular physical activity
- Healthy sleep and circadian rhythm
- Stress reduction techniques
Key Takeaways
Research suggests that mebendazole may have multiple anti-tumor mechanisms, including:
- Microtubule disruption
- Anti-angiogenesis
- Induction of apoptosis
- Inhibition of cancer signaling pathways
While laboratory research is promising, large clinical trials are still needed to determine its role in cancer treatment.
Patients interested in repurposed drug therapies should discuss these options with their oncology team.
To Learn More About Repurposed Drugs for Cancer-
- Fenbendazole and Cancer: What the Research Really Shows”
- Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies”
- Repurposed Drugs in Cancer Therapy: What the Science Shows”
- Metformin and Cancer: Why a Diabetes Drug Is Being Studied for Tumors
- Repurposed Drugs in Cancer Therapy: What the Science Shows
- Repurposed Drugs + Chemotherapy: Integrative Treatment
Research Citation Appendix
- Microtubule inhibition
https://pubmed.ncbi.nlm.nih.gov/20442352/ - Angiogenesis inhibition
https://pubmed.ncbi.nlm.nih.gov/24370321/ - Apoptosis in lung cancer models
https://pubmed.ncbi.nlm.nih.gov/25011444/ - Hedgehog pathway inhibition
https://pubmed.ncbi.nlm.nih.gov/23748255/ - Glioblastoma survival study
https://pubmed.ncbi.nlm.nih.gov/23393386/ - Clinical trial
https://clinicaltrials.gov/ct2/show/NCT01729260 - Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies
- Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies
- Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies